Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor

Jan 22, 2019

Novartis has signed an agreement to collaborate with Compact Imaging – to fund the development of a low-cost home-based monitor to detect disease progression in advanced cases of eye diseases, age-related macular degeneration (AMD) and diabetic retinopathy (DR).

If approved, goggles used at a patient's home could record a test result and upload it over the internet for a specialist to review, thereby potentially reducing clinical visits, saving doctors' and patients' time while delivering cost and efficiency savings to healthcare systems.

This collaboration demonstrates Novartis’s ongoing commitment to eye care and improving patient outcomes for age-related macular degeneration (AMD) and diabetic retinopathy (DR).

  1. Nasdaq. (2018). Compact Imaging Collaborates with Global Pharma to Accelerate Development of Home Monitor for Age-Related Macular Degeneration and Diabetic Retinopathy. [online] Available at: https://www.nasdaq.com/press-release/compact-imaging-collaborates-with-global-pharma-to-accelerate-development-of-home-monitor-for-20181025-00687 [Accessed 26 Nov. 2018].
  2. Reynolds, J. (2018). Novartis to fund medtech startup's eye kit - Independent.ie. [online] Independent.ie. Available at: https://www.independent.ie/business/irish/novartis-to-fund-medtech-startups-eye-kit-37472133.html [Accessed 26 Nov. 2018].